Edmund J Pezalla, MD

Viewpoint

A Payer Expert Analyzes Rare Disease Drug Policy

06/06/2022

Edmund J Pezalla, MD, founder and CEO of Enlightenment Bioconsult, Hartford, CT provides insight on rare disease drug policy noting volume and indication-based contracts as potential solutions for managing costs of therapies.

Edmund J Pezalla, MD, founder...

06/06/2022

First Report Managed Care

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Edmund J Pezalla, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products